Regina Pikman, Pnina Rotman, Natur Aiman, Yair Levy
Department of Medicine E, Meir Medical Center, 44261, Kfar-Saba, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Immunol Res. 2017 Apr;65(2):438-446. doi: 10.1007/s12026-017-8895-1.
Anti-phospholipid syndrome is an autoimmune disorder characterized by anti-phospholipid antibodies, arterial and venous thrombosis, pregnancy morbidity, and various neurological manifestations including psychiatric disorders. Higher incidence of various autoimmune disorders was found in schizophrenia. In addition, an association between the presence of anti-phospholipid antibodies and schizophrenia or psychosis was previously described, mainly as case reports. Although initially believed to be a result of neuroleptic treatment, the reasons for this association remain obscure. Several theories on the etiologic basis of schizophrenia that may explain this association were proposed including an immune basis of schizophrenia and a genetic locus of the disease in the human leukocyte antigens area. Herein, we present a series of five patients diagnosed with both schizophrenia and anti-phospholipid syndrome and their characteristics along with a comprehensive review of the current available literature on the subject in an attempt to deepen our understanding of these disorders and their pathogenesis.
抗磷脂综合征是一种自身免疫性疾病,其特征为抗磷脂抗体、动静脉血栓形成、妊娠并发症以及包括精神障碍在内的各种神经学表现。在精神分裂症患者中发现各种自身免疫性疾病的发病率较高。此外,先前已有文献报道抗磷脂抗体与精神分裂症或精神病之间存在关联,主要是病例报告。尽管最初认为这是抗精神病药物治疗的结果,但这种关联的原因仍不明确。关于精神分裂症病因基础的几种理论被提出来解释这种关联,包括精神分裂症的免疫基础以及人类白细胞抗原区域的疾病基因位点。在此,我们报告了5例同时诊断为精神分裂症和抗磷脂综合征的患者及其特征,并对该主题的现有文献进行了全面综述,以加深我们对这些疾病及其发病机制的理解。